Unique ID issued by UMIN | UMIN000028862 |
---|---|
Receipt number | R000033034 |
Scientific Title | The health benefits of test food (HBF2017-01): a randomized double-blind, paralled-group, placebo-controlled study |
Date of disclosure of the study information | 2017/09/08 |
Last modified on | 2020/01/31 16:29:10 |
The health benefits of test food (HBF2017-01): a randomized double-blind, paralled-group, placebo-controlled study
The health bebefits of test food (HBF2017-01)
The health benefits of test food (HBF2017-01): a randomized double-blind, paralled-group, placebo-controlled study
The health bebefits of test food (HBF2017-01)
Japan |
Healthy Japanease adults
Adult |
Others
NO
To investigate the effect of test food(HBF2017-01) on risk factors for life-style-related diseases in healthy adults
Efficacy
1.Blood glucose after a 2-h OGTT
* Measuring: at 0 and 12 weeks after ingestion
1.Body weight, BMI, Body fat, Truncal fat, Blood pressure, Abdominal circumference, Waist circumference
* Measuring: at 0,8 and 12 weeks after ingestion
2. Blood glucose, Insulin, HbA1c, ALT, AST, gamma-GTP, TG, Total choresterol, HDLchoresterol, LDLchoresterol, PAI-1
* Measuring: at 0 and 12 weeks after ingestion
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Treatment
Food |
Oral ingestion of the test food(HBF2017-01) twice a day(after lunch and after dinner) for 12 weeks
Oral ingestion of the placebo control food twice a day(after lunch and after dinner) for 12 weeks
20 | years-old | <= |
65 | years-old | > |
Male and Female
1)Healthy Japanease adults
2)Employees at the Hayashibara CO.,LTD.
3)Subjects who signed the informed consent for participation in the study
4)Higher BMI, body fat, fasting blood glucose level
1)Subjects with medical history of sever disorders
2)Pregnant or have possibility to become pregnant during the study or lactating women
3)Subjects who judged as unsuitable for this study by the principal investigator for any reasons
4)Subjects who are being treated with hyperglycemia
40
1st name | Chiyo |
Middle name | |
Last name | Yoshizane |
Hayashibara CO., LTD.
R&D Division, Development Unit
7028006
675-1, Fujisaki, Naka-ku, Okayama
086-276-3141
chiyo.yoshizane@hb.nagase.co.jp
1st name | Chiyo |
Middle name | |
Last name | Yoshizane |
Hayashibara CO., LTD.
R&D Division, Development Unit
7028006
675-1, Fujisaki, Naka-ku, Okayama
086-276-3141
chiyo.yoshizane@hb.nagase.co.jp
Hayashibara CO., LTD.
None
Self funding
The Ethics Committee of Hayashibara Co., Ltd.
675-1, Fujisaki, Naka-ku, Okayama
086-276-3141
HB96301@hb.nagase.co.jp
NO
株式会社林原/Hayashibara CO.,LTD.(Okayama)
2017 | Year | 09 | Month | 08 | Day |
Unpublished
Completed
2017 | Year | 06 | Month | 20 | Day |
2017 | Year | 09 | Month | 11 | Day |
2017 | Year | 08 | Month | 28 | Day |
2020 | Year | 01 | Month | 31 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033034
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |